Was noticing that Resverlogix's Twitter account has been a wee bit busier of late, 3 tweets in just the last 10 days...that might be a record.

Scrolled back to one from January, about the news of FDA acceptance of BETonMACE's trial protocol amendments.  Here's the link to the associated PR:

http://www.globenewswire.com/news-release/2018/01/11/1287479/0/en/Resverlogix-Receives-FDA-Protocol-Acceptance-for-the-Ongoing-Phase-3-BETonMACE-Trial.html

That PR mentions the SSRA and brings up the possibility of increasing enrollment.  But obviously an increase was not a requirement for FDA acceptance of the trial.  

Just tossing this out there, I think it might lend some credibility to Don's calling BETonMACE properly powered.  Of course we'll have definitive word, or at least we should...before the calendar turns from June to July...the sooner the better.

Now to bed....